New report on Arthroscopy Devices is the minimally invasive surgical procedure to visualize, diagnose, and treat problems of the joints using an arthroscope. It is commonly performed on joints of the knees, shoulders, hips, elbows, ankles, and wrist among others. An arthroscope comprises probes, soft tissue repair devices, arthroscopes, and fluid management systems. Factors such as increasing incidence of sports-related injuries and growing demand for minimally invasive surgical procedures have fostered the adoption of arthroscopic devices. According to the American Orthopaedic Society for Sports Medicine, around 4 million people undergo knee arthroscopies, whereas the number of patients undergoing shoulder arthroscopies is 1.4 million per annum. Unlike traditional surgical procedures, arthroscopy is suitable for the geriatric population as well as professional athletes owing to its associated benefits such as short recovery period and minimal pain.

Increasing incidence of sports-related musculoskeletal disorders, such as bone tumor, rheumatoid arthritis, and osteoarthritis, have fueled the growth of this market. In addition, ongoing research activities in the sport medicine sector is a major growth factor of the market.

The report segments the market on the basis of application, end user, technology, and geography. Based on application, the market is segmented into knee injuries, shoulder injuries, back and spine injuries, ankle and foot injuries, hip and groin injuries, elbow and wrist injuries, and other injuries. The end users of the market are healthcare institutes, academies, organizations and hospitals. The technologies used in the market include arthroscopes, fluid management systems, RF probes, shoulder soft tissue repair devices, small-joint soft tissue repair devices, arthroscopic manual instruments, powered shavers, knee soft tissue repair devices, hip soft tissue repair devices, and reprocessed devices. The market is analyzed on the basis of four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

In January 2016, Bioventus launched a single injection joint-fluid, Duralone, for osteoarthritis treatment in Taiwan to set its foothold in the patient care market. Similarly, in March 2015, Cayenne Medical launched two new products, Quattro Bolt Tenodesis Screw and the Short SureLock System, which assist surgeons to navigate through intricate joints.